Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital

被引:38
作者
Elabd, Faten M. [1 ]
Al-Ayed, Mohamed S. Z. [2 ]
Asaad, Ahmed M. [2 ]
Alsareii, Saeed A. [3 ]
Qureshi, Mohamed A. [4 ]
Musa, Hassan A. -A. [5 ]
机构
[1] Asser Cent Hosp, Abha, Saudi Arabia
[2] Najran Univ, Coll Med, Najran, Saudi Arabia
[3] Najran Univ, Vice Dean Coll Med, Coll Dent, Najran, Saudi Arabia
[4] Najran Univ, Coll Appl Med Sci, Najran, Saudi Arabia
[5] Natl Ribat Univ, Coll Med, Khartoum, Sudan
关键词
Acinetobacter baumannii; Carbapenemases; Antibiotics; PR; ANTIMICROBIAL RESISTANCE; BLA(OXA) GENES; EMERGENCE; PATHOGENS; STRAINS;
D O I
10.1016/j.jiph.2014.10.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Acinetobacter baumannii has successfully become a significant nosocomial pathogen because of its remarkable ability to acquire antibiotic resistance and to survive in nosocomial environments. This study aimed to determine the drug susceptibility patterns and the distribution of four subgroups of carbapenem-hydrolyzing class D -lactamases (OXA-carbapenemases), as well as their insertion sequences (ISAba1), among A. baumannii nosocomial isolates from a Saudi tertiary care hospital. Methods: A total of 108 non-duplicate A. baumannh isolates were identified, and their susceptibilities to different antibiotics were determined using the breakpoint method. Isolates were then subjected to multiplex-PER targeting bla(OXA) genes. Results: More than 75% of the isolates showed resistance to different antibiotics. The rates of susceptibility to colistin, meropenem, imipenem and trimethoprim sulfamethoxazole were 95.6, 50, 48.1 and 34.3%, respectively. All isolates possessed a bla(OXA-51-like) gene. Of the 56 carbapenem-resistant isolates, 48 isolates (85.7%) carried bla(OXA-23-like), 3 isolates (5.4%) carried bla(OXA-40-like) and two isolates (3.6%) had bla(OXA-58-like) genes. The ISAbal element was found upstream of the bla(OXA-23) and bla(OXA-24) genes in 40 (71.4%) and 3 (5.4%) isolates, respectively, while it was detected upstream of biaoxA.51 in only one (1.8%) isolate. Conclusion: Our findings further illustrate the challenge of increasing carbapenemresistance in A. baumannii isolates in Saudi Arabia. The high distribution of class D carbapenemase-encoding genes, mainly ISAba1/OXA-23 and ISAba1/OXA-24 carbapenemases, is worrisome and presents an emerging threat in our hospital. Local molecular surveillance is essential to help control carbapenem-resistant A. baurnannii nosocomial infections and to prevent DNA exchange among endemic nosocomial pathogens. (C) 2014 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
引用
收藏
页码:242 / 247
页数:6
相关论文
共 30 条
[1]   Distribution of β-lactamases in carbapenem-non-susceptible Acinetobacter baumannii in Riyadh, Saudi Arabia [J].
Al-Agamy, Mohamed H. ;
Shibl, Atef M. ;
Ali, Mohamed S. ;
Khubnani, Harish ;
Radwan, Hesham H. ;
Livermore, David M. .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (01) :17-21
[2]  
Al-Arfaj AA, 2011, AFR J BIOTECHNOL, V10, P14186
[3]  
Aly M, 2014, EUR J CLIN MICROBIOL
[4]   Emergence of Unusual Nonfermenting Gram-Negative Nosocomial Pathogens in a Saudi Hospital [J].
Asaad, Ahmed Morad ;
Al-Ayed, Mohamed Said Zayed ;
Qureshi, Mohamed Ansar .
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (06) :507-511
[5]   Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan [J].
Ben, Ren-Jy ;
Yang, Ming-Chang ;
Hsueh, Jui-Chen ;
Shiang, Jeng-Chuan ;
Chien, Shang-Tao .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (05) :403-408
[6]   Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the blaOXA-23 Gene Associated with ISAba4 in Belgium [J].
Bogaerts, Pierre ;
Cuzon, Gaelle ;
Naas, Thierry ;
Bauraing, Caroline ;
Deplano, Ariane ;
Lissoir, Benedicte ;
Nordmann, Patrice ;
Glupczynski, Youri .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) :4205-4206
[7]  
CARVALHO KR, 2009, BRAZIL INT J ANTIMIC, V34, P25
[8]  
Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIS, pM100
[9]  
Feizabadi MM, 2008, JPN J INFECT DIS, V61, P274
[10]   Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09) [J].
Gales, Ana C. ;
Jones, Ronald N. ;
Sader, Helio S. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (09) :2070-2074